FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing February 16, 2018Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin FDA approves drug to reduce the risk of stage III non-small cell lung cancer progressing